{"id":"W4404048194","doi":"10.3389/fonc.2024.1437360","title":"Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodine-refractory thyroid carcinoma","year":2024,"lang":"en","type":"review","venue":"Frontiers in Oncology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre; University of Toronto; Université de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke; Toronto Western Hospital; Nova Scotia Cancer Centre; University of British Columbia; Princess Margaret Cancer Centre; University of Calgary; Centre Hospitalier de l’Université de Montréal; University of Alberta; University Health Network; Dalhousie University; BC Cancer Agency","funders":"Bayer Canada; EMD Serono; Genentech; BeiGene; Ipsen; Eisai; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Thyroid carcinoma; Radiation therapy; Thyroid cancer; Multidisciplinary approach; Malignancy; Thyroid; Reimbursement; Radioactive iodine; Oncology; Refractory (planetary science); Disease; Intensive care medicine; Internal medicine; Health care","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005884872,0.0007002595,0.001423268,0.003489173,0.0007936807,0.001586281,0.002189294,0.002009491,0.003251034],"category_scores_gemma":[0.008269032,0.0002916199,0.001403617,0.002950567,0.0008075782,0.001294881,0.001284721,0.002635519,0.001488825],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004377801,"about_ca_system_score_gemma":0.01728699,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03524743,"about_ca_topic_score_gemma":0.05684765,"domain_scores_codex":[0.9978139,0.000527296,0.0004477742,0.0001617244,0.0008586411,0.0001906275],"domain_scores_gemma":[0.9953704,0.001236443,0.0003830447,0.00008571189,0.002647756,0.0002766136],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008628442,0.00003386808,0.0005151244,0.02988119,0.0002123586,0.0003510519,0.0003304005,0.0006060729,0.0007653965,0.007253691,0.1693233,0.7906413],"study_design_scores_gemma":[0.0000223052,0.00003173747,0.001095525,0.02372534,0.000239989,0.0007411892,0.0001548297,0.00008922837,0.0002577935,0.00185786,0.9717588,0.0000253074],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002463445,0.9798985,0.0008910074,0.01072771,0.002076021,0.00005552638,0.0002035422,0.00002755821,0.005873766],"genre_scores_gemma":[0.003671455,0.9866604,0.002517701,0.004057471,0.0006357384,0.00005472738,0.0003733911,0.00001387639,0.002015264],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9647526,"threshold_uncertainty_score":0.07008457,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02571575498584898,"score_gpt":0.3205644199417361,"score_spread":0.2948486649558871,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}